Ferric derisomaltose

Ferric derisomaltose
Clinical data
Trade names	Monoferric
AHFS/Drugs.com	Monograph
License data	US DailyMed: Ferric_derisomaltose;
Routes of; administration	Intravenous (IV)
ATC code	None;
Legal status
Legal status	US: ℞-only;
Identifiers
	IUPAC name iron(3+);(2S,3R,4R,5R)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexane-1,2,3,4,5-pentol;
CAS Number	1345510-43-1;
PubChem CID	86278348;
DrugBank	DB15617;
UNII	AHU547PI9H;
KEGG	D11808;
Chemical and physical data
Formula	C18H34FeO16+3
Molar mass	562.299 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(CO)O)O)O)O)O)O)O)O)O)O)O.[Fe+3];
	InChI InChI=1S/C18H34O16.Fe/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18;/h5-30H,1-4H2;/q;+3/t5-,6+,7+,8+,9+,10+,11+,12+,13-,14-,15+,16+,17-,18-;/m0./s1; Key:JTQTXQSGPZRXJF-DOJSGGEQSA-N;

Ferric derisomaltose, sold under the brand name Monoferric, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD).^[1] It was approved for use in the United States in January 2020.^[1]^[2]^[3] It is injected.^[1]

References

^ ^a ^b ^c "Monoferric- ferric derisomaltose solution". DailyMed. 24 January 2020. Retrieved 16 February 2020.
^ "Monoferric approval letter" (PDF). U.S. Food and Drug Administration (FDA). 16 January 2020. Retrieved 16 February 2020. This article incorporates text from this source, which is in the public domain.
^ "Drug Approval Package: Monoferric Injection". U.S. Food and Drug Administration (FDA). 7 May 2020. Retrieved 13 August 2020.

External links

"Ferric derisomaltose". Drug Information Portal. U.S. National Library of Medicine.

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

[Monoferric_FDA_label-1] "Monoferric- ferric derisomaltose solution". DailyMed. 24 January 2020. Retrieved 16 February 2020.

[Monoferric_approval_letter-2] "Monoferric approval letter" (PDF). U.S. Food and Drug Administration (FDA). 16 January 2020. Retrieved 16 February 2020. This article incorporates text from this source, which is in the public domain.

[3] "Drug Approval Package: Monoferric Injection". U.S. Food and Drug Administration (FDA). 7 May 2020. Retrieved 13 August 2020.

[1]

[2]

[3]